Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial

被引:0
|
作者
Madonna Salib
Sophie Girerd
Nicolas Girerd
Winfried März
Hubert Scharnagl
Ziad A. Massy
Céline Leroy
Kévin Duarte
Hallvard Holdaas
Alan G. Jardine
Roland E. Schmieder
Bengt Fellström
Natalia López-Andrés
Patrick Rossignol
Faiez Zannad
机构
[1] CHRU Nancy; F-CRIN INI-CRCT,Université de Lorraine, Inserm, Centre d’Investigations Cliniques
[2] University Hospital of Nancy,1433, and Inserm U1116
[3] University of Heidelberg,Nephrology Department
[4] Medical University of Graz,Medical Clinic V (Nephrology, Hypertensiology, Rheumatology, Endocrinology, Diabetology), Medical Faculty Mannheim
[5] Paris-Saclay University (PSU) and University of Paris Ouest-Versailles-Saint-Quentin-en-Yvelines (UVSQ),Clinical Institute of Medical and Chemical Laboratory Diagnostics
[6] FCRIN INI-CRCT,Division of Nephrology, Ambroise Paré University Hospital, APHP, Boulogne Billancourt/Paris, and INSERM U
[7] University of Oslo,1018, Centre de recherche en épidémiologie et santé des populations (CESP), Equipe 5
[8] University of Glasgow,Medical Department, Rikshospitalet
[9] University Hospital Erlangen,Renal Research Group, British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences
[10] University Hospital,Department of Nephrology and Hypertension
[11] Universidad Pública de Navarra (UPNA),Department of Nephrology
[12] IdiSNA,Navarrabiomed, Complejo Hospitalario de Navarra (CHN)
来源
关键词
Hemodialysis; Collagen; Fibrosis; Biomarker; Galectin-3; Cardiovascular diseases;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:614 / 626
页数:12
相关论文
共 50 条
  • [21] Relationship Between Serum Indirect Bilirubin Levels and Cardiovascular Events and All-Cause Mortality in Maintenance Hemodialysis Patients
    Chen, Yu
    Zhao, Peilei
    Fan, Weifeng
    Niu, Jianying
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 1081 - 1090
  • [22] Association of serum uric acid with all-cause and cardiovascular mortality in cardiovascular disease patients
    Lv, Yan-Lin
    Liu, Yong-Ming
    Dong, Kai-Xuan
    Ma, Xiong-Bin
    Qian, Lin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [23] Association of serum uric acid to all-cause and cardiovascular mortality in patients with cardiovascular disease
    Song, Zikai
    Deng, Dayong
    Wu, Haidi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Statins and All-Cause Mortality in Patients Undergoing Hemodialysis
    Jung, Jaehun
    Bae, Gi Hwan
    Kang, Minsun
    Kim, Soo Wan
    Lee, Dae Ho
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):
  • [25] BODY COMPOSITION AND ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS
    Huang, Cindy
    Tighiouari, Hocine
    Beddhu, Srinivasan
    Cheung, Alferd
    Johanna, Dwyer
    Eknoyan, Garabed
    Beck, Gerald
    Levey, Andre
    Sarnak, Mark
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A43 - A43
  • [26] Salt Intake and All-Cause Mortality in Hemodialysis Patients
    Ikenoue, Tatsuyoshi
    Koike, Kiyomi
    Fukuma, Shingo
    Ogata, Satoshi
    Iseki, Kunitoshi
    Fukuhara, Shunichi
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 48 (02) : 87 - 95
  • [27] THE NOVEL FIBROSIS MARKER GALECTIN 3 ASSOCIATES WITH INFECTIOUS DEATHS, ALL-CAUSE MORTALITY AND CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS
    Drechsler, Christiane
    Wanner, Christoph
    Blouin, Katja
    Pilz, Stefan
    Tomaschitz, Andreas
    Krane, Vera
    Maerz, Winfried
    Ritz, Eberhard
    van der Harst, Pim
    de Boer, Rudolf
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 489 - 489
  • [28] BONE TURNOVER MARKERS ASSOCIATE MORE STRONGLY WITH CARDIOVASCULAR MORTALITY THAN ALL-CAUSE DEATH IN MAINTENANCE HEMODIALYSIS PATIENTS
    Fujii, Naohiko
    Hamano, Takayuki
    Nakano, Chikako
    Yonemoto, Sayoko
    Okuno, Ayako
    Katayama, Masaya
    Isaka, Yoshitaka
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 293 - 293
  • [29] The number of valvular insufficiency is a strong predictor of cardiovascular and all-cause mortality in hemodialysis patients
    Wei, Honglan
    Liu, Shufang
    Tian, Ming
    Shang, Weifeng
    Li, Hua
    Wu, Yang
    Dong, Junwu
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (11) : 2915 - 2924
  • [30] Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients
    Yamashita, Kazuomi
    Mizuiri, Sonoo
    Nishizawa, Yoshiko
    Shigemoto, Kenichiro
    Doi, Shigehiro
    Masaki, Takao
    THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (01) : 31 - 39